Questo sito utilizza i cookie come descritto nel ns Gestione dei Cookie. Per vedere quali cookie serviamo, controlla il nostro Pannello delle impostazioni dei cookie. Sono d'accordo con questa politica sui cookie, non mostrare più questo messaggio

Six 20 Minutes Webcasts

ACR POINT-OF-CARE TESTING: A GAME CHANGER FOR DETECTING AND MANAGING KIDNEY DISEASE

Watch the episodes

DIABETES & CVD
Webcast Series: EVENT 6
Held: July 2023

Prevention and Treatment CKD: Case Study from the Cardiometabolic Institute

DIABETES & CVD
Webcast Series: EVENT 5
Held: June 2023

Kidney Disease? Case Study from a Diabetes and Lipids Outpatient Clinic

DIABETES & CVD
Webcast Series: EVENT 4
Held: May 2023

Albumin-to-Creatinine Ratio (ACR) point-of-care testing: successful implementation in the GP office

DIABETES & CVD
Webcast Series: EVENT 3
Held: March 2023

Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease

DIABETES & CVD
Webcast Series: EVENT 2
Held: February 2023

Should you screen for kidney damage?
What do the guidelines say?

DIABETES & CVD
Webcast Series: EVENT 1
Held: January 2023

ACR – The window to early kidney disease

Background

Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether2 — which is why testing in at-risk groups is so important.

Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it altogether.

Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Series of six livestream events covering:

  • Importance of regular testing for early detection and monitoring in high-risk patients
  • Importance of ACR testing beside the determination of eGFR
  • Latest guidance on disease prevention and management
  • Case studies
Share
Like
Tweet
References
  1. Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
  2. The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease

Presentazioni

  • PROF. STEPHAN JACOB

    PROF. STEPHAN JACOB
    (GERMANY)
    Speaker

    Dr. Jacob is an Endocrinologist, Diabetologist, Nutrition Expert and Clinical Hypertension Specialist in Private Practice.

  • DR. HELMUT BRATH

    DR. HELMUT BRATH
    (AUSTRIA)
    Speaker

  • DR. KRISTIAN JONG HØINES

    DR. KRISTIAN JONG HØINES
    (NORWAY)
    Speaker

    Specialist General Practitioner in Tananger and Assistant Professor at the Department of Global Public Health and Primary Care at the University of Bergen.

  • PROF. GOTTFRIED RUDOFSKY

    PROF. GOTTFRIED RUDOFSKY
    (SWITZERLAND)
    Speaker

    Specialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland.

  • PROF. PETER ROSSING

    PROF. PETER ROSSING
    (DENMARK)
    Speaker

    Head of department for Complications Research at Steno Diabetes Center Copenhagen, and Professor in Endocrinology at Department of Clinical Medicine, University of Copenhagen.

  • PROF. TROND JENSSEN

    PROF. TROND JENSSEN
    (NORWAY)
    Speaker

    Professor of Nephrology in the Department of Clinical Medicine, University of Oslo, and leader of the Research Group for Transplantation Medicine, Section of Nephrology, Rikshospitalet, Oslo University Hospital.

Le opinioni e le opinioni presentate sono solo degli autori. Il contenuto di questo webcast è destinato esclusivamente a scopi informativi/didattici.

© 2022 Abate. Tutti i diritti riservati. Tutti i marchi citati sono marchi del gruppo di società Abbott o dei rispettivi proprietari. COL-16422 01/2023

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"it","eventsSlug":"acr-point-of-care-testing-a-game-changer-for-detecting-and-managing-kidney-disease"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"it","eventsSlug":"acr-point-of-care-testing-a-game-changer-for-detecting-and-managing-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/it/events/acr-point-of-care-testing-a-game-changer-for-detecting-and-managing-kidney-disease"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"it","eventsSlug":"acr-point-of-care-testing-a-game-changer-for-detecting-and-managing-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/it/events/acr-point-of-care-testing-a-game-changer-for-detecting-and-managing-kidney-disease"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/it/events/acr-point-of-care-testing-a-game-changer-for-detecting-and-managing-kidney-disease"

"-- SEO4AJAX --" "Bugsnag Called"